BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Y, Chen AQ, Xue Y, Liu MF, Liu C, Liu YH, Pan YP, Diao HL, Chen L. Orexins alleviate motor deficits via increasing firing activity of pallidal neurons in a mouse model of Parkinson's disease. Am J Physiol Cell Physiol 2019;317:C800-12. [PMID: 31365289 DOI: 10.1152/ajpcell.00125.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Mu F, Jiao Q, Du X, Jiang H. Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis. Neurol Sci 2020;41:1419-26. [DOI: 10.1007/s10072-020-04277-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Tabikh M, Chahla C, Okdeh N, Kovacic H, Sabatier J, Fajloun Z. Parkinson disease: protective role and function of neuropeptides. Peptides 2021. [DOI: 10.1016/j.peptides.2021.170713] [Reference Citation Analysis]
3 Chen XY, Xue Y, Chen H, Chen L. The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities. Peptides 2020;124:170210. [PMID: 31778724 DOI: 10.1016/j.peptides.2019.170210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Seigneur E, de Lecea L. Hypocretin (Orexin) Replacement Therapies. Medicine in Drug Discovery 2020;8:100070. [DOI: 10.1016/j.medidd.2020.100070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Pan YP, Liu C, Liu MF, Wang Y, Bian K, Xue Y, Chen L. Involvement of orexin-A in the regulation of neuronal activity and emotional behaviors in central amygdala in rats. Neuropeptides 2020;80:102019. [PMID: 31980205 DOI: 10.1016/j.npep.2020.102019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
6 Mogavero MP, Silvani A, DelRosso LM, Salemi M, Ferri R. Focus on the Complex Interconnection between Cancer, Narcolepsy and Other Neurodegenerative Diseases: A Possible Case of Orexin-Dependent Inverse Comorbidity. Cancers (Basel) 2021;13:2612. [PMID: 34073579 DOI: 10.3390/cancers13112612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu C, Xue Y, Liu MF, Wang Y, Chen L. Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential. Neurochem Int 2020;138:104754. [PMID: 32422324 DOI: 10.1016/j.neuint.2020.104754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bian K, Liu C, Wang Y, Xue Y, Chen L. Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice. Neurosci Lett 2021;765:136291. [PMID: 34666119 DOI: 10.1016/j.neulet.2021.136291] [Reference Citation Analysis]
9 Yang X, Zhu S, Jin N, Li Y, Zhen C, Zhang H, Xu A, Wang M, Zheng C. [Orexin-A inhibits γ-aminobutyric acid current of neonatal rat spinal cord ventral horn neurons by activating OX1R, OX2R and Ca2+-independent PKC]. Nan Fang Yi Ke Da Xue Xue Bao 2021;41:694-701. [PMID: 34134956 DOI: 10.12122/j.issn.1673-4254.2021.05.09] [Reference Citation Analysis]
10 Wang Y, Xue Y, Liu C, Chen L. Apelin-13 regulates electrical activity in the globus pallidus and induces postural changes in rats. Neural Regen Res 2021;16:2264-8. [PMID: 33818511 DOI: 10.4103/1673-5374.310694] [Reference Citation Analysis]